PhRMA: Nearly Half Of 2018 Drug Spending Went To Supply Chain

Nearly half of total 2018 spending on brand name medicines went to the supply chain and brand drug makers are retaining an increasingly smaller share of list prices, according to an industry-funded study by the Berkeley Research Group. Biopharmaceutical companies retained 54% of total spending on brand name medicines and the share of spending received by other stakeholders has increased from 33% in 2013 to 46% in 2018, the study found. Pharmaceutical Research and Manufacturers of America President and CEO...